An investigation of a non-invasive device to alert people with type 1 diabetes to the presence of nocturnal hypoglycaemia
Recruiting
- Conditions
- Type 1 diabetes
- Registration Number
- ACTRN12617000814370
- Lead Sponsor
- St Vincent's Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie microtremor detection for nocturnal hypoglycaemia in type 1 diabetes?
How does non-invasive microtremor monitoring compare to continuous glucose monitoring in type 1 diabetes management?
Are there specific biomarkers that correlate with microtremor changes during hypoglycaemic episodes in type 1 diabetes patients?
What adverse events are associated with microtremor and temperature-based hypoglycaemia detection devices in clinical use?
What are the current non-invasive hypoglycaemia alert technologies being developed by pharmaceutical companies for type 1 diabetes?